Evolution AB trades at multiyear lows, reflecting sentiment shifts, regulatory fears, and growth deceleration. EVVTY now combines attributes of a premium compounder and a defensive value play, ...
Ten years ago, I would have turned my nose up at the idea that we already understood how to get machines to think. In the 2010s, my team at Google Research was working on a wide variety of ...
Markets are rebounding, prompting a review of new investment opportunities following my sale of British American Tobacco. Evolution AB emerges as a compelling replacement, sharing BTI's strengths but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback